| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.0054 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |